SEI Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-1,835
Closed -$260K – 2483
2020
Q3
$260K Sell
1,835
-2,432
-57% -$405K ﹤0.01% 2147
2020
Q2
$842K Sell
4,267
-2,764
-39% -$572K ﹤0.01% 1624
2020
Q1
$1.38M Sell
7,031
-1,994
-22% -$429K 0.01% 1313
2019
Q4
$1.87M Buy
9,025
+2,371
+36% +$438K 0.01% 1368
2019
Q3
$1.02M Sell
6,654
-5,878
-47% -$963K ﹤0.01% 1596
2019
Q2
$1.62M Buy
12,532
+1,773
+16% +$210K 0.01% 1411
2019
Q1
$1.27M Buy
10,759
+10,731
+38,325% +$1.08M ﹤0.01% 1503
2018
Q4
$3K Hold
28
– – ﹤0.01% 2604
2018
Q3
$3K Buy
+28
New +$2.96K ﹤0.01% 2472

Other funds holding LKFT

SEI Investments's LKFT Position: Q4 2020 in Review

SEI Investments sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2020, closing a stake of 1,835 shares — an estimated $260K sold.

SEI Investments first reported a position in LKFT in Q3 2018 and held it in 9 quarters. The position peaked at $1.87M in Q4 2019. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.

  • SEI Investments reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • SEI Investments sold 1,835 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $260K.
  • SEI Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and held it in 9 quarters.
  • SEI Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.87M in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.

Based on SEI Investments's 13F filing for Q4 2020, filed 8 Feb 2021.